Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis

NCT02887079 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT02887079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02887079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
December 31, 2016
Enrollment
186 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infective endocarditis